Top Stories
-
Diagnosed with stage 3 bladder cancer, Jeffrey Pulver underwent chemo, surgery, and a neobladder at Columbia—just in time to walk his daughter down the aisle, cancer-free, on their family farm.
-
Two teams at the Vagelos College of Physicians and Surgeons are working to train patients’ immune cells to seek and destroy rogue cells that cause cancer and autoimmune diseases.
Topic
-
Columbia cell therapy pioneer Michel Sadelain has received the 2025 Merkin Prize in Biomedical Technology and the 2025 King Faisal Prize in Medicine.
Topic
-
Columbia researchers are uncovering potential new therapies to counter the changing identities of cancer cells.
Topic
Latest News
- March 7, 2017
The drug, developed by Columbia and MSK researchers, selectively kills cancer cells and has shown activity against multiple malignancies in pre-clinical studies.
- February 14, 2017
In her JAMA editorial, Columbia oncologist Dawn Hershman says clinical trials show cooling caps reduce hair loss in some women undergoing chemotherapy.
Topic
- January 12, 2017
Collaboration will investigate a system biology approach to identifying treatment options for patients with advanced gastrointestinal stromal tumors (GIST).
Topic
- December 22, 2016
Columbia University researchers have created a user-friendly program that rapidly predicts which genes are implicated in an individual’s cancer and recommends treatments.
Topic
- December 16, 2016
Researchers have found that blocking nerve growth factor inhibits the formation of stomach cancers, according to a study in mice.
Topic
- December 5, 2016
In a phase 1 study, eight out of 12 patients with relapsed and/or refractory blood cancers responded to a combination of two common chemotherapy drugs.
Topic
- November 4, 2016
Dr. Drake studies the body’s immunological response to radiation therapy and how immunotherapy and radiation therapy can be used in concert to treat cancer.
Topic
- September 14, 2016
In mice studies, targeting the SET protein revives p53, a potent tumor suppressor, and prevents cancer growth.
Topic
